Sandor Lovas - Publications

Affiliations: 
Biomedical Science Creighton University, Omaha, NE, United States 
Area:
Biochemistry, Pharmaceutical Chemistry

61 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Holmes TR, Al-Matouq J, Holmes M, Sioda N, Rudd JC, Bloom C, Nicola L, Palermo NY, Madson JG, Lovas S, Hansen LA. Targeting 14-3-3ε activates apoptotic signaling to prevent cutaneous squamous cell carcinoma. Carcinogenesis. PMID 32816038 DOI: 10.1093/carcin/bgaa091  0.56
2016 Knappe D, Goldbach T, Hatfield MP, Palermo NY, Weinert S, Sträter N, Hoffmann R, Lovas S. Proline-rich Antimicrobial Peptides Optimized for Binding to Escherichia coli Chaperone DnaK. Protein and Peptide Letters. PMID 27449941  0.84
2016 Knappe D, Goldbach T, Hatfield MP, Palermo NY, Weinert S, Sträter N, Hoffmann R, Lovas S. Proline-rich Antimicrobial Peptides Optimized for Binding to Escherichia coli Chaperone DnaK. Protein and Peptide Letters. PMID 27449938  0.84
2015 Lovas S, He DZ, Liu H, Tang J, Pecka JL, Hatfield MP, Beisel KW. Glutamate transporter homolog-based model predicts that anion-π interaction is the mechanism for the voltage-dependent response of prestin. The Journal of Biological Chemistry. 290: 24326-39. PMID 26283790 DOI: 10.1074/jbc.M115.649962  0.84
2015 Otvos L, Kovalszky I, Olah J, Coroniti R, Knappe D, Nollmann FI, Hoffmann R, Wade JD, Lovas S, Surmacz E. Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling. Biopolymers. 104: 156-66. PMID 25683126 DOI: 10.1002/bip.22627  0.36
2015 Lovas S, He DZZ, Liu H, Tang J, Pecka JL, Hatfield MPD, Beisel KW. Glutamate transporter homolog-based model predicts that anion-π interaction is the mechanism for the voltage-dependent response of prestin Journal of Biological Chemistry. 290: 24326-24339. DOI: 10.1074/jbc.M115.649962  0.56
2014 Otvos L, Knappe D, Hoffmann R, Kovalszky I, Olah J, Hewitson TD, Stawikowska R, Stawikowski M, Cudic P, Lin F, Wade JD, Surmacz E, Lovas S. Development of second generation peptides modulating cellular adiponectin receptor responses. Frontiers in Chemistry. 2: 93. PMID 25368867 DOI: 10.3389/fchem.2014.00093  0.56
2014 Molnár G, Faragó N, Kocsis ÁK, Rózsa M, Lovas S, Boldog E, Báldi R, Csajbók É, Gardi J, Puskás LG, Tamás G. GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 1133-7. PMID 24453306 DOI: 10.1523/JNEUROSCI.4082-13.2014  0.56
2014 Hatfield MP, Lovas S. Conformational sampling techniques. Current Pharmaceutical Design. 20: 3303-13. PMID 23947647  0.84
2013 Faragó N, Kocsis ÁK, Lovas S, Molnár G, Boldog E, Rózsa M, Szemenyei V, Vámos E, Nagy LI, Tamás G, Puskás LG. Digital PCR to determine the number of transcripts from single neurons after patch-clamp recording. Biotechniques. 54: 327-36. PMID 23750542 DOI: 10.2144/000114029  0.56
2012 Hatfield MP, Lovas S. Role of Hsp70 in cancer growth and survival. Protein and Peptide Letters. 19: 616-24. PMID 22519533  0.84
2012 Palermo NY, Thomas P, Murphy RF, Lovas S. Hexapeptide fragment of carcinoembryonic antigen which acts as an agonist of heterogeneous ribonucleoprotein M. Journal of Peptide Science : An Official Publication of the European Peptide Society. 18: 252-60. PMID 22392880 DOI: 10.1002/psc.2393  0.56
2011 Otvos L, Haspinger E, La Russa F, Maspero F, Graziano P, Kovalszky I, Lovas S, Nama K, Hoffmann R, Knappe D, Cassone M, Wade J, Surmacz E. Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. Bmc Biotechnology. 11: 90. PMID 21974986 DOI: 10.1186/1472-6750-11-90  0.36
2011 Kim BH, Palermo NY, Lovas S, Zaikova T, Keana JF, Lyubchenko YL. Single-molecule atomic force microscopy force spectroscopy study of Aβ-40 interactions. Biochemistry. 50: 5154-62. PMID 21553928 DOI: 10.1021/bi200147a  0.56
2011 Hatfield MP, Murphy RF, Lovas S. The CLN025 decapeptide retains a β-hairpin conformation in urea and guanidinium chloride. The Journal of Physical Chemistry. B. 115: 4971-81. PMID 21480621 DOI: 10.1021/jp111076j  0.56
2011 Otvos L, Kovalszky I, Scolaro L, Sztodola A, Olah J, Cassone M, Knappe D, Hoffmann R, Lovas S, Hatfield MP, Beko G, Zhang S, Wade JD, Surmacz E. Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation. Biopolymers. 96: 117-25. PMID 20564005 DOI: 10.1002/bip.21377  0.84
2010 Kovalszky I, Surmacz E, Scolaro L, Cassone M, Ferla R, Sztodola A, Olah J, Hatfield MP, Lovas S, Otvos L. Leptin-based glycopeptide induces weight loss and simultaneously restores fertility in animal models. Diabetes, Obesity & Metabolism. 12: 393-402. PMID 20415687 DOI: 10.1111/j.1463-1326.2009.01170.x  0.84
2010 Hatfield MP, Murphy RF, Lovas S. Molecular dynamics analysis of the conformations of a beta-hairpin miniprotein. The Journal of Physical Chemistry. B. 114: 3028-37. PMID 20148510 DOI: 10.1021/jp910465e  0.56
2010 Hatfield MP, Murphy RF, Lovas S. VCD spectroscopic properties of the beta-hairpin forming miniprotein CLN025 in various solvents. Biopolymers. 93: 442-50. PMID 19937759 DOI: 10.1002/bip.21356  0.56
2009 Copps J, Murphy RF, Lovas S. The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers. Protein and Peptide Letters. 16: 1504-18. PMID 20001914 DOI: 10.2174/092986609789839269  0.56
2009 Copps J, Murphy RF, Lovas S. The structure of bioactive analogs of the N-terminal region of gastrin-17. Peptides. 30: 2250-62. PMID 19766682 DOI: 10.1016/j.peptides.2009.09.016  0.56
2009 Copps J, Ahmed S, Murphy RF, Lovas S. Bioactivity of analogs of the N-terminal region of gastrin-17. Peptides. 30: 2263-7. PMID 19761808 DOI: 10.1016/j.peptides.2009.09.012  0.56
2009 Palermo NY, Csontos J, Murphy RF, Lovas S. The impact of aromatic residues on the tertiary fold of avian pancreatic polypeptide. Advances in Experimental Medicine and Biology. 611: 89-90. PMID 19400107 DOI: 10.1007/978-0-387-73657-0_40  0.56
2009 Csontos J, Murphy RF, Lovas S. The energetics of weakly polar interactions in model tripeptides. Advances in Experimental Medicine and Biology. 611: 79-80. PMID 19400102 DOI: 10.1007/978-0-387-73657-0_35  0.56
2008 Hatfield MP, Palermo NY, Csontos J, Murphy RF, Lovas S. Evaluation of methods to cap molecular fragments in calculating energies of interaction in avian pancreatic polypeptide. International Journal of Quantum Chemistry. 108: 1017-1021. PMID 18985167 DOI: 10.1002/qua.21553  0.56
2008 Palermo NY, Csontos J, Murphy RF, Lovas S. The Role of Aromatic Residues in Stabilizing the Secondary and Tertiary Structure of Avian Pancreatic Polypeptide. International Journal of Quantum Chemistry. 108: 814-819. PMID 18985166 DOI: 10.1002/qua.21521  0.56
2008 Copps J, Murphy RF, Lovas S. Molecular dynamics simulations of peptides. Methods in Molecular Biology (Clifton, N.J.). 494: 115-26. PMID 18726571 DOI: 10.1007/978-1-59745-419-3_7  0.56
2008 Csontos J, Murphy RF, Lovas S. The role of weakly polar and H-bonding interactions in the stabilization of the conformers of FGG, WGG, and YGG: an aqueous phase computational study. Biopolymers. 89: 1002-11. PMID 18615659 DOI: 10.1002/bip.21049  0.56
2008 Komáromi I, Owen MC, Murphy RF, Lovas S. Development of glycyl radical parameters for the OPLS-AA/L force field. Journal of Computational Chemistry. 29: 1999-2009. PMID 18366017 DOI: 10.1002/jcc.20962  0.56
2008 Hatfield MP, Palermo NY, Csontos J, Murphy RF, Lovas S. Quantum chemical quantification of weakly polar interaction energies in the TC5b miniprotein. The Journal of Physical Chemistry. B. 112: 3503-8. PMID 18303883 DOI: 10.1021/jp077674h  0.56
2008 Csontos J, Kálmán P, Tasi G, Kálmán M, Murphy RF, Lovas S. The effect of electron correlation on the conformational space of melatonin. Journal of Computational Chemistry. 29: 1466-71. PMID 18270961 DOI: 10.1002/jcc.20907  0.56
2008 Csontos J, Palermo NY, Murphy RF, Lovas S. Calculation of weakly polar interaction energies in polypeptides using density functional and local Møller-Plesset perturbation theory. Journal of Computational Chemistry. 29: 1344-52. PMID 18172837 DOI: 10.1002/jcc.20898  0.56
2007 Masman MF, Lovas S, Murphy RF, Enriz RD, Rodríguez AM. Conformational preferences of N-acetyl-L-leucine-N'-methylamide. Gas-phase and solution calculations on the model dipeptide. The Journal of Physical Chemistry. A. 111: 10682-91. PMID 17887655 DOI: 10.1021/jp0716886  0.56
2007 Borics A, Murphy RF, Lovas S. Conformational analysis of Ac-NPGQ-NH2 and Ac-VPaH-NH 2 by vibrational circular dichroism spectroscopy combined with molecular dynamics and quantum chemical calculations Protein and Peptide Letters. 14: 353-359. PMID 17504093 DOI: 10.2174/092986607780363907  0.56
2007 Copps J, Murphy RF, Lovas S. VCD spectroscopic and molecular dynamics analysis of the Trp-cage miniprotein TC5b Biopolymers - Peptide Science Section. 88: 427-437. PMID 17326200 DOI: 10.1002/bip.20709  0.56
2007 Palermo NY, Csontos J, Owen MC, Murphy RF, Lovas S. Aromatic-backbone interactions in model α-helical peptides Journal of Computational Chemistry. 28: 1208-1214. PMID 17299770 DOI: 10.1002/JCC.20837  0.56
2007 Copps J, Ahmed S, Murphy RF, Lovas S. Gastrin 1-6 promotes growth of colon cancer cells through non-CCK receptors. Peptides. 28: 632-5. PMID 17126952 DOI: 10.1016/j.peptides.2006.10.008  0.56
2007 Borics A, Murphy RF, Lovas S. Optical spectroscopic elucidation of β-turns in disulfide bridged cyclic tetrapeptides Biopolymers. 85: 1-11. PMID 16948119 DOI: 10.1002/bip.20593  0.56
2007 Ötvös F, Gembitsky DS, Murphy RF, Lovas S. Synthesis and structure-activity relationship of [Nle10] neurokinin A (4-10) analogs with constraint in the backbone and at position six International Journal of Peptide Research and Therapeutics. 13: 329-336. DOI: 10.1007/s10989-007-9087-y  0.56
2006 Herédi-Szabó K, Murphy RF, Lovas S. Is IGnRH-III the most potent GnRH analog containing only natural amino acids that specifically inhibits the growth of human breast cancer cells? Journal of Peptide Science. 12: 714-720. PMID 16967433 DOI: 10.1002/psc.783  0.56
2006 Copps J, Murphy RF, Lovas S. Avian pancreatic polypeptide fragments refold to native aPP conformation when combined in solution: A CD and VCD study Biopolymers. 83: 32-38. PMID 16628551 DOI: 10.1002/bip.20524  0.56
2006 Owen MC, Komáromi I, Murphy RF, Lovas S. The conformational preference of Cα-centered radicals in proteins Journal of Molecular Structure: Theochem. 759: 117-124. DOI: 10.1016/j.theochem.2005.10.047  0.56
2006 Herédi-Szabó K, Murphy RF, Lovas S. Different signal responses to lamprey GnRH-III in human cancer cells International Journal of Peptide Research and Therapeutics. 12: 359-364. DOI: 10.1007/s10989-006-9039-y  0.56
2005 Chass GA, Mirasol RS, Setiadi DH, Tang TH, Chin W, Mons M, Dimicoli I, Dognon JP, Viskolcz B, Lovas S, Penke B, Csizmadia IG. Characterization of the conformational probability of N-acetyl-phenylalanyl-NH2 by RHF, DFT, and MP2 computation and AIM analyses, confirmed by jet-cooled infrared data. The Journal of Physical Chemistry. A. 109: 5289-302. PMID 16839052 DOI: 10.1021/jp040720i  0.56
2005 Ahmed S, Murphy RF, Lovas S. Importance of N- and C-terminal regions of gastrin-Gly for preferential binding to high and low affinity gastrin-Gly receptors. Peptides. 26: 1207-12. PMID 15949639 DOI: 10.1016/j.peptides.2005.02.001  0.56
2005 Herédi-Szabó K, Lubke J, Toth G, Murphy RF, Lovas S. Importance of the central region of lamprey gonadotropin-releasing hormone III in the inhibition of breast cancer cell growth Peptides. 26: 419-422. PMID 15652648 DOI: 10.1016/j.peptides.2004.10.007  0.56
2004 Ahmed S, Budai B, Herédi-Szabó K, Farkas J, Tóth G, Murphy RF, Lovas S. High and low affinity receptors mediate growth effects of gastrin and gastrin-Gly on DLD-1 human colonic carcinoma cells. Febs Letters. 556: 199-203. PMID 14706850  0.56
2003 Borics A, Murphy RF, Lovas S. Fourier transform vibrational circular dichroism as a decisive tool for conformational studies of peptides containing tyrosyl residues. Biopolymers. 72: 21-4. PMID 12400088 DOI: 10.1002/bip.10247  0.56
2003 Lau SK, Chass GA, Lovas S, Penke B, Csizmadia IG. An exploratory ab initio conformational analysis of selected fragments of nicotinamide adenine dinucleotide (NAD+). Part I: 5-Deoxyribose nicotinamide N-glycoside Journal of Molecular Structure: Theochem. 666: 415-429. DOI: 10.1016/j.theochem.2003.08.117  0.56
2003 Borics A, Chass GA, Csizmadia IG, Murphy RF, Lovas S. The benefits of a pre-computed amino acid structure database in quantum chemical geometry optimizations of β-turns of peptides Journal of Molecular Structure: Theochem. 666: 355-359. DOI: 10.1016/j.theochem.2003.08.046  0.56
2003 Sahai MA, Lovas S, Chass GA, Penke B, Csizmadia IG. A modular numbering system of selected oligopeptides for molecular computations: Using pre-computed amino acid building blocks Journal of Molecular Structure: Theochem. 666: 169-218. DOI: 10.1016/j.theochem.2003.08.028  0.56
2003 Bhattacharjee S, Tóth G, Lovas S, Hirst JD. Influence of tyrosine on the electronic circular dichroism of helical peptides Journal of Physical Chemistry B. 107: 8682-8688.  0.56
2002 Kragol G, Hoffmann R, Chattergoon MA, Lovas S, Cudic M, Bulet P, Condie BA, Rosengren KJ, Montaner LJ, Otvos L. Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. European Journal of Biochemistry / Febs. 269: 4226-37. PMID 12199701 DOI: 10.1046/j.1432-1033.2002.03119.x  0.56
2002 Gembitsky DS, Bozsó Z, O'Flaharty M, Otvös F, Murphy RF, Lovas S. A specific binding site for a fragment of the B-loop of epidermal growth factor and related peptides. Peptides. 23: 97-102. PMID 11814623  0.56
2002 Chass GA, Lovas S, Murphy RF, Csizmadia IG. The role of enhanced aromatic π-electron donating aptitude of the tyrosyl sidechain with respect to that of phenylalanyl in intramolecular interactions European Physical Journal D. 20: 481-497. DOI: 10.1140/epjd/e2002-00155-6  0.56
2001 Murphy LO, Cluck MW, Lovas S, Otvös F, Murphy RF, Schally AV, Permert J, Larsson J, Knezetic JA, Adrian TE. Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions. British Journal of Cancer. 84: 926-35. PMID 11286473 DOI: 10.1054/bjoc.2001.1698  0.56
1999 Pályi I, Vincze B, Lovas S, Mezö I, Pató J, Kálnay A, Turi G, Gaál D, Mihalik R, Péter I, Teplán I, Murphy RF. Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity. Proceedings of the National Academy of Sciences of the United States of America. 96: 2361-6. PMID 10051647 DOI: 10.1073/pnas.96.5.2361  0.56
1997 Mezö I, Lovas S, Pályi I, Vincze B, Kálnay A, Turi G, Vadász Z, Seprödi J, Idei M, Tóth G, Gulyás E, Otvös F, Mák M, Horváth JE, Teplán I, et al. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships. Journal of Medicinal Chemistry. 40: 3353-8. PMID 9341910 DOI: 10.1021/jm9700981  0.56
1995 Boman BM, Lovas S, Abraham C, Adrian TE, Murphy RF, Marbello R, Bhattacharya G. Radioimmunoassay of the APC Gene Product Using Antibodies against Its Middle and Carboxyl Regions Biochemical and Biophysical Research Communications. 206: 909-915. PMID 7832804 DOI: 10.1006/bbrc.1995.1129  0.56
1994 Lovas S, Smith DD, Murnin M, Allen J, Murphy RF. Structure-activity relationships of para-substituted Phe analogues of [Nle10]NKA(4-10). Biochemical Society Transactions. 22: 5S. PMID 8206276 DOI: 10.1042/bst022005s  0.56
1993 Sower SA, Chiang YC, Lovas S, Conlon JM. Primary structure and biological activity of a third gonadotropin-releasing hormone from lamprey brain. Endocrinology. 132: 1125-31. PMID 8440174 DOI: 10.1210/endo.132.3.8440174  0.56
Show low-probability matches.